Revisited and revised: Is RhoA always a villain in cardiac pathophysiology?

Journal of Cardiovascular Translational Research

Volumn 3, Issue 4, 2010, Pages 330-343

  Miyamoto, Shigeki ^a   Del Re, Dominic P ^a   Xiang, Sunny Y ^a   Zhao, Xia ^a   Florholmen, Geir ^a   Brown, Joan Heller ^a  

^a San Diego   (United States)

Author keywords

Cardiomyocyte ischemia; RhoA; ROCK

Indexed keywords

CYSTEINE RICH PROTEIN 61; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE C; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE D; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SERUM RESPONSE FACTOR; BIOLOGICAL MARKER;

ARTICLE; CARDIAC MUSCLE CELL; CELL DEATH; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HEART DISEASE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CARDIOMEGALY; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HEART; HEART MUSCLE; HEART MUSCLE CELL; METABOLISM; MOUSE; PATHOPHYSIOLOGY; RAT; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; HEART; HEART FAILURE; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 78349234696     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-010-9192-8     Document Type: Article

References (214)

1. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an α1-adrenergic response. Journal of Clinical Investigation 1983;72:732. [PubMed: 6135712]
2. Shubeita HE, McDonough PM, Harris AN, Knowlton KU, Glembotski CC, Brown JH, et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. The Journal of Biological Chemistry 1990;265:20555. [PubMed: 2173712]
3. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circulation Research 1982;51:787. [PubMed: 6216022]
4. Knowlton KU, Michel MC, Itani M, Shubeita HE, Ishihara K, Brown JH, et al. The α1a-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. The Journal of Biological Chemistry 1993;268:15374. [PubMed: 8393439]
5. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ, et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The Journal of Biological Chemistry 1994;269:1110. [PubMed: 7507104]
6. McDonough PM, Brown JH, Glembotski CC. Phenylephrine and endothelin differentially stimulate cardiac PI hydrolysis and ANF expression. The American Journal of Physiology 1993;264:H625. [PubMed: 8383460]
7. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, et al. Endothelin-1 is an autocrine/ paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. Journal of Clinical Investigation 1993;92:398. [PubMed: 8326007]
8. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proceedings of the National Academy of Sciences of the United States of America 1997;94:8121. [PubMed: 9223325]
9. Dorn GW, Brown JH. Gq signaling in cardiac adaptation and maladaptation. Trends in Cardiovascular Medicine 1999;9:26. [PubMed: 10189964]
10. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, et al. Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proceedings of the National Academy of Sciences of the United States of America 1998;95:10140. [PubMed: 9707614]
11. Akhter SA, Luttrell LM, Rockman HA, Iaccarino G, Lefkowitz RJ, Koch WJ. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 1998;280:574. [PubMed: 9554846]
12. Wettschureck N, Rutten H, Zywietz A, Gehring D, Wilkie TM, Chen J, et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Natural Medicines 2001;7:1236.
13. Smrcka AV, Hepler JR, Brown KO, Sternweis PC. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science 1991;251:804. [PubMed: 1846707]
14. Taylor SJ, Chae HZ, Rhee SG, Exton JH. Activation of the β1 isozyme of phospholipase C by α subunits of the Gq class of G proteins. Nature 1991;350:516. [PubMed: 1707501]
15. Dorn GW, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. Journal of Clinical Investigation 2005;115:527. [PubMed: 15765134]
16. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nature Reviews. Molecular Cell Biology 2006;7:589.
17. Thorburn J, Xu S, Thorburn A. MAP kinase-and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. The EMBO Journal 1997;16:1888. [PubMed: 9155015]
18. Maruyama Y, Nishida M, Sugimoto Y, Tanabe S, Turner JH, Kozasa T, et al. Gα12/13 mediates α1-adrenergic receptor-induced cardiac hypertrophy. Circulation Research 2002;91:961. [PubMed: 12433842]
19. Sah VP, Hoshijima M, Chien KR, Brown JH. Rho is required for Gαq and α1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. Journal of Biological Chemistry 1996;271:31185. [PubMed: 8940118]
20. Amano M, Fukata Y, Kaibuchi K. Regulation and functions of Rho-associated kinase. Experimental Cell Research 2000;261:44. [PubMed: 11082274]
21. Noma K, Oyama N, Liao JK. Physiological role of ROCKs in the cardiovascular system. American Journal of Physiology. Cell Physiology 2006;290:C661. [PubMed: 16469861]
22. Chaulet H, Desgranges C, Renault MA, Dupuch F, Ezan G, Peiretti F, et al. Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circulation Research 2001;89:772. [PubMed: 11679406]
23. Hoshijima M, Sah VP, Wang Y, Chien KR, Brown JH. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes: Involvement of Rho kinase. The Journal of Biological Chemistry 1998;273:7725. [PubMed: 9516480]
24. Yanazume T, Hasegawa K, Wada H, Morimoto T, Abe M, Kawamura T, et al. Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy. The Journal of Biological Chemistry 2002;277:8618. [PubMed: 11739382]
25. Kawamura S, Miyamoto S, Brown JH. Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: Cytoskeletal regulation of ERK translocation. The Journal of Biological Chemistry 2003;278:31111. [PubMed: 12777392]
26. Torsoni AS, Marin TM, Velloso LA, Franchini KG. RhoA/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes. American Journal of Physiology. Heart and Circulatory Physiology 2005;289:H1488. [PubMed: 15923313]
27. Torsoni AS, Fonseca PM, Crosara-Alberto DP, Franchini KG. Early activation of p160ROCK by pressure overload in rat heart. American Journal of Physiology. Cell Physiology 2003;284:C1411. [PubMed: 12570982]
28. Phrommintikul A, Tran L, Kompa A, Wang B, Adrahtas A, Cantwell D, et al. Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. American Journal of Physiology. Heart and Circulatory Physiology 2008;294:H1804. [PubMed: 18245565]
29. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: Effect on endothelial NAD(P)H oxidase system. Circulation Research 2003;93:767. [PubMed: 14500337]
30. Rossman KL, Der CJ, Sondek J. GEF means go: Turning on RHO GTPases with guanine nucleotide-exchange factors. Nature Reviews. Molecular Cell Biology 2005;6:167.
31. Loirand G, Guerin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circulation Research 2006;98:322. [PubMed: 16484628]
32. Brown JH, Del Re DP, Sussman MA. The Rac and Rho hall of fame: A decade of hypertrophic signaling hits. Circulation Research 2006;98:730. [PubMed: 16574914]
33. Kodaki T, Yamashita S. Cloning, expression, and characterization of a novel phospholipase D complementary DNA from rat brain. The Journal of Biological Chemistry 1997;272:11408. [PubMed: 9111050]
34. Rojas RJ, Yohe ME, Gershburg S, Kawano T, Kozasa T, Sondek J. Gαq directly activates p63RhoGEF and Trio via a conserved extension of the Dbl homology-associated pleckstrin homology domain. The Journal of Biological Chemistry 2007;282:29201. [PubMed: 17606614]
35. Lutz S, Freichel-Blomquist A, Yang Y, Ruemenapp U, Jakobs KH, Schmidt M, et al. The guanine nucleotide exchange factor p63Rho. Journal of Biological Chemistry. 2005
36. Riobo NA, Manning DR. Receptors coupled to heterotrimeric G proteins of the G12 family. Trends in Pharmacological Sciences 2005;26:146. [PubMed: 15749160]
37. Strathmann MP, Simon MI. Gα12 and Gα13 subunits define a fourth class of G protein α subunits. Proceedings of the National Academy of Sciences of the United States of America 1993;88:5582. [PubMed: 1905812]
38. Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, et al. p115 RhoGEF, a GTPase activating protein for Gα12 and Gα 13. Science 1998;280:2109. [PubMed: 9641915]
39. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, et al. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Gα 13. Science 1998;280:2112. [PubMed: 9641916]
40. Lezoualc'h F, Metrich M, Hmitou I, Duquesnes N, Morel E. Small GTP-binding proteins and their regulators in cardiac hypertrophy. Journal of Molecular and Cellular Cardiology 2008;44:623-632. [PubMed: 18339399]
41. Aittaleb M, Boguth CA, Tesmer JJ. Structure and function of heterotrimeric g protein-regulated rho guanine nucleotide exchange factors. Molecular Pharmacology 2009;77:111-125. [PubMed: 19880753]
42. Diviani D, Soderling J, Scott JD. AKAP-Lbc anchors protein kinase A and nucleates Gα12-selective Rho-mediated stress fiber formation. The Journal of Biological Chemistry 2001;276:44247. [PubMed: 11546812]
43. Appert-Collin A, Cotecchia S, Nenniger-Tosato M, Pedrazzini T, Diviani D. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates α1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proceedings of the National Academy of Sciences of the United States of America 2007;104:10140. [PubMed: 17537920]
44. Finn SG, Plonk SG, Fuller SJ. Gα13 stimulates gene expression and increases cell size in cultured neonatal rat ventricular myocytes. Cardiovascular Research 1999;42:140. [PubMed: 10435005]
45. Arai K, Maruyama Y, Nishida M, Tanabe S, Takagahara S, Kozasa T, et al. Differential requirement of Gα12, Gα13, Gαq, and G βγ for endothelin-1-induced c-Jun NH2-terminal kinase and extracellular signal-regulated kinase activation. Molecular Pharmacology 2003;63:478. [PubMed: 12606754]
46. Nishida M, Sato Y, Uemura A, Narita Y, Tozaki-Saitoh H, Nakaya M, et al. P2Y6 receptor-Gα12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. The EMBO Journal 2008;27:3104. [PubMed: 19008857]
47. Esposito G, Prasad SV, Rapacciuolo A, Mao L, Koch WJ, Rockman HA. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation 2001;103:1453. [PubMed: 11245652]
48. Zhang YM, Bo J, Taffet GE, Chang J, Shi J, Reddy AK, et al. Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. The FASEB Journal 2006;20:916. [PubMed: 16675849]
49. Shi J, Zhang YW, Summers LJ, Dorn GW, Wei L. Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy. Journal of Molecular and Cellular Cardiology 2008;44:551. [PubMed: 18178218]
50. Del Re DP, Miyamoto S, Brown JH. RhoA/Rho kinase upregulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. The Journal of Biological Chemistry 2007;282:8069. [PubMed: 17234627]
51. Del Re DP, Miyamoto S, Brown JH. Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection. The Journal of Biological Chemistry 2008;283:35622. [PubMed: 18854312]
52. Ishii I, Ye X, Friedman B, Kawamura S, Contos JJA, Kingsbury MA, et al. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3. The Journal of Biological Chemistry 2002;277:25152. [PubMed: 12006579]
53. Sah VP, Minamisawa S, Tam SP, Wu TH, Dorn GW, Ross J Jr, et al. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. Journal of Clinical Investigation 1999;103:1627. [PubMed: 10377168]
54. Kontaridis MI, Yang W, Bence KK, Cullen D, Wang B, Bodyak N, et al. Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signalregulated kinase/mitogen-activated protein kinase and RhoA signaling pathways. Circulation 2008;117:1423. [PubMed: 18316486]
55. Rikitake Y, Oyama N, Wang CY, Noma K, Satoh M, Kim HH, et al. Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/− haploinsufficient mice. Circulation 2005;112:2959. [PubMed: 16260635]
56. Kobayashi N, Horinaka S, Mita S, Nakano S, Honda T, Yoshida K, et al. Critical role of Rhokinase pathway for cardiac performance and remodeling in failing rat hearts. Cardiovascular Research 2002;55:757. [PubMed: 12176125]
57. Satoh S, Ueda Y, Koyanagi M, Kadokami T, Sugano M, Yoshikawa Y, et al. Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure. Journal of Molecular and Cellular Cardiology 2003;35:59. [PubMed: 12623300]
58. Hattori T, Shimokawa H, Higashi M, Hiroki J, Mukai Y, Tsutsui H, et al. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 2004;109:2234. [PubMed: 15096457]
59. Chang J, Xie M, Shah VR, Schneider MD, Entman ML, Wei L, et al. Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2006;103:14495. [PubMed: 16983089]
60. Bao W, Hu E, Tao L, Boyce R, Mirabile R, Thudium DT, et al. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovascular Research 2004;61:548. [PubMed: 14962485]
61. Hamid SA, Bower HS, Baxter GF. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. American Journal of Physiology. Heart and Circulatory Physiology 2007;292:H2598. [PubMed: 17220176]
62. Sahai E, Alberts AS, Treisman R. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization. SRF activation and transformation. EMBO Journal 1998;17:1350. [PubMed: 9482732]
63. Nelson CM, Pirone DM, Tan JL, Chen CS. Vascular endothelial-cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA. Molecular Biology of the Cell 2004;15:2943. [PubMed: 15075376]
64. Zhao Z, Rivkees SA. Rho-associated kinases play a role in endocardial cell differentiation and migration. Developmental Biology 2004;275:183. [PubMed: 15464581]
65. Rikitake Y, Liao JK. Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation 2005;111:3261. [PubMed: 15956119]
66. Alblas J, Ulfman L, Hordijk P, Koenderman L. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Molecular Biology of the Cell 2001;12:2137. [PubMed: 11452009]
67. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemiareperfusion injury. Physiological Reviews 2008;88:581. [PubMed: 18391174]
68. Aghajanian A, Wittchen ES, Campbell SL, Burridge K. Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS ONE 2009;4:38045.
69. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arteriosclerosis, Thrombosis, and Vascular Biology 2004;24:1842.
70. Adams JW, Brown JH. G-proteins in growth and apoptosis: Lessons from the heart. Oncogene 2001;20:1626. [PubMed: 11313910]
71. Foo RS, Mani K, Kitsis RN. Death begets failure in the heart. Journal of Clinical Investigation 2005;115:565. [PubMed: 15765138]
72. Dorn GW. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovascular Research 2009;81:465. [PubMed: 18779231]
73. Parsons JT. Focal adhesion kinase: The first ten years. Journal of Cell Science 2003;116:1409. [PubMed: 12640026]
74. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Current Opinion in Cell Biology 2006;18:516. [PubMed: 16919435]
75. Hakim ZS, DiMichele LA, Rojas M, Meredith D, Mack CP, Taylor JM. FAK regulates cardiomyocyte survival following ischemia/reperfusion. Journal of Molecular and Cellular Cardiology 2009;46:241. [PubMed: 19028502]
76. Chong LD, Traynor-Kaplan A, Bokoch GM, Schwartz MA. The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell 1994;79:507. [PubMed: 7954816]
77. Ren X-D, Bokoch GM, Traynor-Kaplan A, Jenkins GH, Anderson RA, Schwartz MA. Physical association of the small GTPase Rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in Swiss 3T3 cells. Molecular Biology of the Cell 1996;7:435. [PubMed: 8868471]
78. Schmidt M, Bienek C, Rumenapp U, Zhang C, Lummen G, Jakobs KH, et al. A role for Rho in receptor-and G protein-stimulated phospholipase C. Reduction in phosphatidylinositol 4, 5-bisphosphate by Clostridium difficile toxin b. Naunyn-Schmiedeberg's Archives of Pharmacology 1996;354:87.
79. Mejillano M, Yamamoto M, Rozelle AL, Sun H-Q, Wang X, Yin HL. Regulation of apoptosis by phosphatidylinositol 4,5 bisphosphate, inhibition of caspases, and caspase inactivation of phosphatidylinositol phosphate 5 kinases. Journal of Biological Chemistry. 2000 In Press.
80. Howes AL, Arthur JF, Zhang T, Miyamoto S, Adams JW, Dorn GW II, et al. Akt-mediated cardiomyocyte survival pathways are compromised by G α q-induced phosphoinositide 4, 5-bisphosphate depletion. The Journal of Biological Chemistry 2003;278:40343. [PubMed: 12900409]
81. Wing MR, Bourdon DM, Harden TK. PLC-ε: A shared effector protein in Ras-, Rho-, and G αβγ-mediated signaling. Molecular Interventions 2003;3:273. [PubMed: 14993441]
82. Bunney TD, Katan M. Phospholipase Cε: Linking second messengers and small GTPases. Trends in Cell Biology 2006;16:640. [PubMed: 17085049]
83. Citro S, Malik S, Oestreich EA, Radeff-Huang J, Kelley GG, Smrcka AV, et al. Phospholipase Cε is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation. Proceedings of the National Academy of Sciences of the United States of America 2007;104:15543. [PubMed: 17878312]
84. Wing MR, Snyder JT, Sondek J, Harden TK. Direct activation of phospholipase C-ε by Rho. The Journal of Biological Chemistry 2003;278:41253. [PubMed: 12900402]
85. Kelley GG, Reks SE, Smrcka AV. Hormonal regulation of phospholipase Cε through distinct and overlapping pathways involving G12 and Ras family G-proteins. The Biochemical Journal 2004;378:129. [PubMed: 14567755]
86. Song C, Hu CD, Masago M, Kariyai K, Yamawaki-Kataoka Y, Shibatohge M, et al. Regulation of a novel human phospholipase C, PLCε, through membrane targeting by Ras. The Journal of Biological Chemistry 2001;276:2752. [PubMed: 11022048]
87. Jin TG, Satoh T, Liao Y, Song C, Gao X, Kariya K, et al. Role of the CDC25 homology domain of phospholipase Cε in amplification of Rap1-dependent signaling. The Journal of Biological Chemistry 2001;276:30301. [PubMed: 11395506]
88. Schmidt M, Evellin S, Weernink PA, von Dorp F, Rehmann H, Lomasney JW, et al. A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nature Cell Biology 2001;3:1020.
89. Kelley GG, Reks SE, Ondrako JM, Smrcka AV. Phospholipase Cε: A novel Ras effector. The EMBO Journal 2001;20:743. [PubMed: 11179219]
90. Lopez I, Mak EC, Ding J, Hamm HE, Lomasney JW. A novel bifunctional phospholipase C that is regulated by Gα 12 and stimulates the Ras/mitogen-activated protein kinase pathway. The Journal of Biological Chemistry 2001;276:2758. [PubMed: 11022047]
91. Hains MD, Wing MR, Maddileti S, Siderovski DP, Harden TK. Gα12/13-and Rho-dependent activation of phospholipase C-ε by lysophosphatidic acid and thrombin receptors. Molecular Pharmacology 2006;69:2068. [PubMed: 16554409]
92. Satoh T, Edamatsu H, Kataoka T. Phospholipase Ce guanine nucleotide exchange factor activity and activation of Rap 1. Methods in Enzymology 2007;407:281. [PubMed: 16757332]
93. Kelley GG, Kaproth-Joslin KA, Reks SE, Smrcka AV, Wojcikiewicz RJ. G-protein-coupled receptor agonists activate endogenous phospholipase Cε and phospholipase Cβ3 in a temporally distinct manner. The Journal of Biological Chemistry 2006;281:2639. [PubMed: 16314422]
94. 2+ release in the heart by activation of protein kinase cε and calcium-calmodulin kinase II. The Journal of Biological Chemistry 2009;284:1514. [PubMed: 18957419]
95. Yujiri T, Sather S, Fanger GR, Johnson GL. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science 1998;282:1911. [PubMed: 9836645]
96. Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, et al. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 2004;109:1938. [PubMed: 15096454]
97. Purcell NH, Wilkins BJ, York A, Saba-El-Leil MK, Meloche S, Robbins J, et al. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proceedings of the National Academy of Sciences of the United States of America 2007;104:14074. [PubMed: 17709754]
98. Inagaki K, Churchill E, Mochly-Rosen D. Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovascular Research 2006;70:222. [PubMed: 16635641]
99. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. Journal of Molecular and Cellular Cardiology 1999;31:1937. [PubMed: 10525430]
100. Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Messing RO, et al. Role of the protein kinase C-ε-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 2005;112:1971. [PubMed: 16172266]
101. Zhang WH, Lu FH, Zhao YJ, Wang LN, Tian Y, Pan ZW, et al. Post-conditioning protects rat cardiomyocytes via PKCε-mediated calcium-sensing receptors. Biochemical and Biophysical Research Communications 2007;361:659. [PubMed: 17673178]
102. Sivaraman V, Hausenloy DJ, Kolvekar S, Hayward M, Yap J, Lawrence D, et al. The divergent roles of protein kinase Cε and δ in simulated ischaemia-reperfusion injury in human myocardium. Journal of Molecular and Cellular Cardiology 2009;46:758. [PubMed: 19248786]
103. Wang H, Oestreich EA, Maekawa N, Bullard TA, Vikstrom KL, Dirksen RT, et al. Phospholipase Cε modulates β-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy. Circulation Research 2005;97:1305. [PubMed: 16293787]
104. Yoshimura S, Nakashima S, Ohguchi K, Sakai H, Shinoda J, Sakai N, et al. Differential mRNA expression of phospholipase D (PLD) isozymes during cAMP-induced differentiation in C6 glioma cells. Biochemical and Biophysical Research Communications 1996;225:494. [PubMed: 8753790]
105. Hammond SM, Jenco JM, Nakashima S, Cadwallader K, Gu Q, Cook S, et al. Characterization of two alternately spliced forms of phospholipase D 1. Activation of the purified enzymes by phosphatidylinositol 4, 5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-α. The Journal of Biological Chemistry 1997;272:3860. [PubMed: 9013646]
106. Redina OE, Frohman MA. Organization and alternative splicing of the murine phospholipase D2 gene. The Biochemical Journal 1998;331(Pt 3):845. [PubMed: 9560313]
107. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, et al. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Current Biology 1997;7:191. [PubMed: 9395408]
108. Bae CD, Min DS, Fleming IN, Exton JH. Determination of interaction sites on the small G protein RhoA for phospholipase D. The Journal of Biological Chemistry 1998;273:11596. [PubMed: 9565577]
109. Sung TC, Zhang Y, Morris AJ, Frohman MA. Structural analysis of human phospholipase D 1. The Journal of Biological Chemistry 1999;274:3659. [PubMed: 9920915]
110. Xie Z, Ho WT, Spellman R, Cai S, Exton JH. Mechanisms of regulation of phospholipase D1 and D2 by the heterotrimeric G proteins G13 and Gq. The Journal of Biological Chemistry 2002;277:11979. [PubMed: 11812783]
111. Du G, Altshuller YM, Kim Y, Han JM, Ryu SH, Morris AJ, et al. Dual requirement for rho and protein kinase C in direct activation of phospholipase D1 through G protein-coupled receptor signaling. Molecular Biology of the Cell 2000;11:4359. [PubMed: 11102529]
112. Schmidt M, Rumenapp U, Bienek C, Keller J, von Eichel-Streiber C, Jakobs KH. Inhibition of receptor signaling to phospholipase D by Clostridium difficile toxin B. Role of Rho proteins. The Journal of Biological Chemistry 1996;271:2422. [PubMed: 8576201]
113. Schmidt M, Voss M, Oude Weernink PA, Wetzel J, Amano M, Kaibuchi K, et al. A role for Rhokinase in Rho-controlled phospholipase D stimulation by the m3 muscarinic acetylcholine receptor. The Journal of Biological Chemistry 1999;274:14648. [PubMed: 10329658]
114. Yamazaki M, Zhang Y, Watanabe H, Yokozeki T, Ohno S, Kaibuchi K, et al. Interaction of the small G protein RhoA with the C terminus of human phospholipase D 1. The Journal of Biological Chemistry 1999;274:6035. [PubMed: 10037681]
115. Schmidt M, Nehls C, Rumenapp U, Jakobs KH. m3 Muscarinic receptor-induced and Gimediated heterologous potentiation of phospholipase C stimulation: Role of phosphoinositide synthesis. Molecular Pharmacology 1996;50:1038. [PubMed: 8863852]
116. Miyamoto S, Murphy AN, Brown JH. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death and Differentiation 2008;15:521. [PubMed: 18064042]
117. Miyamoto S, Murphy AN, Brown JH. Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue. Journal of Bioenergetics and Biomembranes 2009;41:169. [PubMed: 19377835]
118. Lecour S. Activation of the protective survivor activating factor enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? Journal of Molecular and Cellular Cardiology 2009;47:32. [PubMed: 19344728]
119. Lecour S. Multiple protective pathways against reperfusion injury: A SAFE path without Aktion? Journal of Molecular and Cellular Cardiology 2009;46:607. [PubMed: 19318238]
120. Taher MM, Mahgoub MA, Abd-Elfattah AS. Redox regulation of signal transduction in vascular smooth muscle cells: thiol oxidizing agents induced phospholipase D. Biochemistry and Molecular Biology International 1998;46:619. [PubMed: 9818101]
121. 2-induced activation of endothelial cell phospholipase D. The American Journal of Physiology 1996;271:L400. [PubMed: 8843788]
122. Parinandi NL, Scribner WM, Vepa S, Shi S, Natarajan V. Phospholipase D activation in endothelial cells is redox sensitive. Antioxidants Redox Signaling 1999;1:193. [PubMed: 11228747]
123. Banno Y, Wang S, Ito Y, Izumi T, Nakashima S, Shimizu T, et al. Involvement of ERK and p38 MAP kinase in oxidative stress-induced phospholipase D activation in PC12 cells. NeuroReport 2001;12:2271. [PubMed: 11447348]
124. Kim JH, Lee S, Park JB, Lee SD, Kim JH, Ha SH, et al. Hydrogen peroxide induces association between glyceraldehyde 3-phosphate dehydrogenase and phospholipase D2 to facilitate phospholipase D2 activation in PC12 cells. Journal of Neurochemistry 2003;85:1228. [PubMed: 12753082]
125. Dai J, Meij JT, Padua R, Panagia V. Depression of cardiac sarcolemmal phospholipase D activity by oxidant-induced thiol modification. Circulation Research 1992;71:970. [PubMed: 1516167]
126. Dai J, Meij JT, Dhalla V, Panagia V. Involvement of thiol groups in the impairment of cardiac sarcoplasmic reticular phospholipase D activity by oxidants. Journal of Lipid Mediators and Cell Signalling 1995;11:107. [PubMed: 7780680]
127. Asemu G, Dent MR, Singal T, Dhalla NS, Tappia PS. Differential changes in phospholipase D and phosphatidate phosphohydrolase activities in ischemia-reperfusion of rat heart. Archives of Biochemistry and Biophysics 2005;436:136. [PubMed: 15752718]
128. Bruhl A, Faldum A, Loffelholz K. Degradation of phosphatidylethanol counteracts the apparent phospholipase D-mediated formation in heart and other organs. Biochimica et Biophysica Acta 2003;1633:84. [PubMed: 12880867]
129. Kurz T, Kemken D, Mier K, Weber I, Richardt G. Human cardiac phospholipase D activity is tightly controlled by phosphatidylinositol 4, 5-bisphosphate. Journal of Molecular and Cellular Cardiology 2004;36:225. [PubMed: 14871550]
130. Cohen MV, Liu Y, Liu GS, Wang P, Weinbrenner C, Cordis GA, et al. Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation 1996;94:1713. [PubMed: 8840865]
131. Tosaki A, Maulik N, Cordis G, Trifan OC, Popescu LM, Das DK. Ischemic preconditioning triggers phospholipase D signaling in rat heart. The American Journal of Physiology 1997;273:H1860. [PubMed: 9362254]
132. Mozzicato S, Joshi BV, Jacobson KA, Liang BT. Role of direct RhoA-phospholipase D1 interaction in mediating adenosine-induced protection from cardiac ischemia. The FASEB Journal 2004;18:406. [PubMed: 14688204]
133. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, et al. PKC-α regulates cardiac contractility and propensity toward heart failure. Natural Medicines 2004;10:248.
134. Liu Q, Chen X, MacDonnell SM, Kranias EG, Lorenz JN, Leitges M, et al. Protein kinase Cα, but not PKCβ or PKCγ, regulates contractility and heart failure susceptibility: Implications for ruboxistaurin as a novel therapeutic approach. Circulation Research 2009;105:194. [PubMed: 19556521]
135. Saurin AT, Pennington DJ, Raat NJ, Latchman DS, Owen MJ, Marber MS. Targeted disruption of the protein kinase Cε gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovascular Research 2002;55:672. [PubMed: 12160964]
136. Zatta AJ, Kin H, Lee G, Wang N, Jiang R, Lust R, et al. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovascular Research 2006;70:315. [PubMed: 16443207]
137. Mayr M, Metzler B, Chung YL, McGregor E, Mayr U, Troy H, et al. Ischemic preconditioning exaggerates cardiac damage in PKC-δ null mice. American Journal of Physiology. Heart and Circulatory Physiology 2004;287:H946. [PubMed: 15277209]
138. Churchill EN, Szweda LI. Translocation of δPKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function. Archives of Biochemistry and Biophysics 2005;439:194. [PubMed: 15963450]
139. Churchill EN, Murriel CL, Chen CH, Mochly-Rosen D, Szweda LI. Reperfusion-induced translocation of δPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circulation Research 2005;97:78. [PubMed: 15961716]
140. Inagaki K, Chen L, Ikeno F, Lee FH, Imahashi K, Bouley DM, et al. Inhibition of δ-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 2003;108:2304. [PubMed: 14597593]
141. Murriel CL, Churchill E, Inagaki K, Szweda LI, Mochly-Rosen D. Protein kinase Cδ activation induces apoptosis in response to cardiac ischemia and reperfusion damage: A mechanism involving BAD and the mitochondria. The Journal of Biological Chemistry 2004;279:47985. [PubMed: 15339931]
142. Murriel CL, Mochly-Rosen D. Opposing roles of δ and εPKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery. Archives of Biochemistry and Biophysics 2003;420:246. [PubMed: 14654063]
143. Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, et al. Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and εPKC. Proceedings of the National Academy of Sciences of the United States of America 2001;98:11114. [PubMed: 11553773]
144. Inagaki K, Hahn HS, Dorn GW, Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and ε-protein kinase C activator. Circulation 2003;108:869. [PubMed: 12860903]
145. Haworth RS, Roberts NA, Cuello F, Avkiran M. Regulation of protein kinase D activity in adult myocardium: novel counter-regulatory roles for protein kinase Cε and protein kinase A. Journal of Molecular and Cellular Cardiology 2007;43:686. [PubMed: 17964599]
146. Rey O, Reeve JR Jr, Zhukova E, Sinnett-Smith J, Rozengurt E. G protein-coupled receptormediated phosphorylation of the activation loop of protein kinase D: Dependence on plasma membrane translocation and protein kinase Cε. The Journal of Biological Chemistry 2004;279:34361. [PubMed: 15190080]
147. Brandlin I, Eiseler T, Salowsky R, Johannes FJ. Protein kinase Cμ regulation of the JNK pathway is triggered via phosphoinositide-dependent kinase 1 and protein kinase Cε. The Journal of Biological Chemistry 2002;277:45451. [PubMed: 12223477]
148. Tan M, Xu X, Ohba M, Ogawa W, Cui MZ. Thrombin rapidly induces protein kinase D phosphorylation, and protein kinase C δ mediates the activation. The Journal of Biological Chemistry 2003;278:2824. [PubMed: 12431976]
149. Haworth RS, Cuello F, Herron TJ, Franzen G, Kentish JC, Gautel M, et al. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circulation Research 2004;95:1091. [PubMed: 15514163]
150. Cuello F, Bardswell SC, Haworth RS, Yin X, Lutz S, Wieland T, et al. Protein kinase D selectively targets cardiac troponin I and regulates myofilament Ca2+ sensitivity in ventricular myocytes. Circulation Research 2007;100:864. [PubMed: 17322173]
151. Huynh QK, McKinsey TA. Protein kinase D directly phosphorylates histone deacetylase 5 via a random sequential kinetic mechanism. Archives of Biochemistry and Biophysics 2006;450:141. [PubMed: 16584705]
152. Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Molecular and Cellular Biology 2004;24:8374. [PubMed: 15367659]
153. Dequiedt F, Van LJ, Lecomte E, Van D, Seufferlein VT, Vandenheede JR, et al. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. The Journal of Experimental Medicine 2005;201:793. [PubMed: 15738054]
154. Storz P, Toker A. Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. The EMBO Journal 2003;22:109. [PubMed: 12505989]
155. Storz P, Doppler H, Toker A. Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Molecular and Cellular Biology 2005;25:8520. [PubMed: 16166634]
156. Avkiran M, Rowland AJ, Cuello F, Haworth RS. Protein kinase d in the cardiovascular system: Emerging roles in health and disease. Circulation Research 2008;102:157. [PubMed: 18239146]
157. Yuan J, Slice LW, Rozengurt E. Activation of protein kinase D by signaling through Rho and the α subunit of the heterotrimeric G protein G 13. The Journal of Biological Chemistry 2001;276:38619. [PubMed: 11507098]
158. Cowell CF, Yan IK, Eiseler T, Leightner AC, Doppler H, Storz P. Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D 1. Journal of Cellular Biochemistry 2009;106:714. [PubMed: 19173301]
159. Song J, Li J, Lulla A, Evers BM, Chung DH. Protein kinase D protects against oxidative stressinduced intestinal epithelial cell injury via Rho/ROK/PKC-δ pathway activation. American Journal of Physiology. Cell Physiology 2006;290:C1469. [PubMed: 16421204]
160. Laudanna C, Campbell JJ, Butcher EC. Role of Rho in chemoattractant-activated leukocyte adhesion through integrins. Science 1996;271:981. [PubMed: 8584934]
161. Kaibuchi K, Kuroda S, Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annual Review of Biochemistry 1999;68:459.
162. Seasholtz TM, Majumdar M, Kaplan DD, Brown JH. Rho and Rho kinase mediate thrombinstimulated vascular smooth muscle cell DNA synthesis and migration. Circulation Research 1999;84:1186. [PubMed: 10347093]
163. Schmitz AA, Govek EE, Bottner B, Van Aelst L. Rho GTPases: Signaling, migration, and invasion. Experimental Cell Research 2000;261:1. [PubMed: 11082269]
164. Ridley AJ. Rho GTPases and cell migration. Journal of Cell Science 2001;114:2713. [PubMed: 11683406]
165. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002;420:629. [PubMed: 12478284]
166. Sahai E, Marshall C. RHO-GTPases and cancer. Nature Reviews 2002;2:133.
167. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Developmental Biology 2004;265:23. [PubMed: 14697350]
168. Jaffe AB, Hall A. Rho GTPases: Biochemistry and biology. Annual Review of Cell and Developmental Biology 2005;21:247.
169. Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochimica et Biophysica Acta 2007;1773:642. [PubMed: 16926057]
170. Hill CS, Wynne J, Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 1995;81:1159. [PubMed: 7600583]
171. Gauthier-Rouviere C, Cavadore JC, Blanchard JM, Lamb NJ, Fernandez A. p67SRF is a constitutive nuclear protein implicated in the modulation of genes required throughout the G1 period. Cell Regulation 1991;2:575. [PubMed: 1782216]
172. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 1995;80:199. [PubMed: 7834740]
173. Bence K, Ma W, Kozasa T, Huang X-Y. Direct stimulation of Bruton's tyrosine kinase by Gqprotein α-subunit. Nature 1997;389:296. [PubMed: 9305846]
174. Fromm C, Coso OA, Montaner S, Xu N, Gutkind JS. The small GTP-binding protein Rho links G protein-coupled receptors and Gα12 to the serum response element and to cellular transformation. Proceedings of the National Academy of Sciences of the United States of America 1997;91:10098. [PubMed: 9294169]
175. Shore P, Sharrocks AD. The MADS-box family of transcription factors. European Journal of Biochemistry 1995;229:1. [PubMed: 7744019]
176. Treisman R. Ternary complex factors: Growth factor regulated transcriptional activators. Current Opinion in Genetics & Development 1994;4:96. [PubMed: 8193547]
177. Cen B, Selvaraj A, Burgess RC, Hitzler JK, Ma Z, Morris SW, et al. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Molecular and Cellular Biology 2003;23:6597. [PubMed: 12944485]
178. Cen B, Selvaraj A, Prywes R. Myocardin/MKL family of SRF coactivators: Key regulators of immediate early and muscle specific gene expression. Journal of Cellular Biochemistry 2004;93:74. [PubMed: 15352164]
179. Posern G, Treisman R. Actin' together: Serum response factor, its cofactors and the link to signal transduction. Trends in Cell Biology 2006;16:588. [PubMed: 17035020]
180. Johansen FE, Prywes R. Serum response factor: Transcriptional regulation of genes induced by growth factors and differentiation. Biochimica et Biophysica Acta 1995;1242:1. [PubMed: 7626651]
181. Ueyama T, Sakoda T, Kawashima S, Hiraoka E, Hirata K, Akita H, et al. Activated RhoA stimulates c-fos gene expression in myocardial cells. Circulation Research 1997;81:672. [PubMed: 9351440]
182. Morissette MR, Sah VP, Glembotski CC, Brown JH. The Rho effector, PKN, regulates ANF gene transcription in cardiomyocutes through a serum response element. The American Journal of Physiology 2000;278:H1769.
183. Wang DZ, Li S, Hockemeyer D, Sutherland L, Wang Z, Schratt G, et al. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proceedings of the National Academy of Sciences of the United States of America 2002;99:14855. [PubMed: 12397177]
184. Parmacek MS. Myocardin-related transcription factors: Critical coactivators regulating cardiovascular development and adaptation. Circulation Research 2007;100:633. [PubMed: 17363709]
185. Sotiropoulos A, Gineitis D, Copeland J, Treisman R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 1999;98:159. [PubMed: 10428028]
186. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001;105:851. [PubMed: 11439182]
187. Wang Z, Wang DZ, Pipes GC, Olson EN. Myocardin is a master regulator of smooth muscle gene expression. Proceedings of the National Academy of Sciences of the United States of America 2003;100:7129. [PubMed: 12756293]
188. Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 2003;113:329. [PubMed: 12732141]
189. Lockman K, Hinson JS, Medlin MD, Morris D, Taylor JM, Mack CP. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. The Journal of Biological Chemistry 2004;279:42422. [PubMed: 15292266]
190. Geneste O, Copeland JW, Treisman R. LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics. The Journal of Cell Biology 2002;157:831. [PubMed: 12034774]
191. Muehlich S, Wang R, Lee SM, Lewis TC, Dai C, Prywes R. Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization. Molecular and Cellular Biology 2008;28:6302. [PubMed: 18694962]
192. Vartiainen MK, Guettler S, Larijani B, Treisman R. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 2007;316:1749. [PubMed: 17588931]
193. Arsenian S, Weinhold B, Oelgeschlager M, Ruther U, Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. The EMBO Journal 1998;17:6289. [PubMed: 9799237]
194. Du KL, Chen M, Li J, Lepore JJ, Mericko P, Parmacek MS. Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells. The Journal of Biological Chemistry 2004;279:17578. [PubMed: 14970199]
195. Selvaraj A, Prywes R. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent. BMC Molecular Biology 2004;5:13. [PubMed: 15329155]
196. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004;363:62. [PubMed: 14723997]
197. Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. Journal of Cell Science 2006;119:4803. [PubMed: 17130294]
198. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. International Journal of Biochemistry & Cell Biology. 2008
199. Brigstock DR. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocrine Reviews 1999;20:189. [PubMed: 10204117]
200. Yang GP, Lau LF. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth & Differentiation 1991;2:351. [PubMed: 1782153]
201. O'Brien TP, Yang GP, Sanders L, Lau LF. Expression of cyr61, a growth factor-inducible immediate-early gene. Molecular and Cellular Biology 1990;10:3569. [PubMed: 2355916]
202. Kireeva ML, Mo FE, Yang GP, Lau LF. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Molecular and Cellular Biology 1996;16:1326. [PubMed: 8657105]
203. Chen Y, Du XY. Functional properties and intracellular signaling of CCN1/Cyr 61. Journal of Cellular Biochemistry 2007;100:1337. [PubMed: 17171641]
204. Walsh CT, Stupack D, Brown JH. G protein-coupled receptors go extracellular: RhoA integrates the integrins. Molecular Interventions 2008;8:165. [PubMed: 18829842]
205. Tamura I, Rosenbloom J, Macarak E, Chaqour B. Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways. American Journal of Physiology. Cell Physiology 2001;281:C1524. [PubMed: 11600415]
206. Chaqour B, Goppelt-Struebe M. Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins. The FEBS Journal 2006;273:3639. [PubMed: 16856934]
207. Yang R, Amir J, Liu H, Chaqour B. Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis. Physiological Genomics 2008;36:1. [PubMed: 18854370]
208. Hanna M, Liu H, Amir J, Sun Y, Morris SW, Siddiqui M, et al. Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of the myocardinrelated transcription factor (MRTF)-A and CREB binding protein (CBP) histone acetyl transferase. The Journal of Biological Chemistry 2009;284:23125. [PubMed: 19542562]
209. Gabrielsen A, Lawler PR, Yongzhong W, Steinbruchel D, Blagoja D, Paulsson-Berne G, et al. Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. Journal of Molecular and Cellular Cardiology 2007;42:870. [PubMed: 17343875]
210. Wittchen F, Suckau L, Witt H, Skurk C, Lassner D, Fechner H, et al. Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. Journal of Molecular Medicine 2007;85:257. [PubMed: 17106732]
211. Hilfiker-Kleiner D, Kaminski K, Kaminska A, Fuchs M, Klein G, Podewski E, et al. Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation 2004;109:2227. [PubMed: 15117851]
212. Han JS, Macarak E, Rosenbloom J, Chung KC, Chaqour B. Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways. European Journal of Biochemistry 2003;270:3408. [PubMed: 12899698]
213. Young N, Van B Jr. Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. Experimental Cell Research 2007;313:1615. [PubMed: 17376432]
214. Yoshida Y, Togi K, Matsumae H, Nakashima Y, Kojima Y, Yamamoto H, et al. CCN1 protects cardiac myocytes from oxidative stress via β1 integrin-Akt pathway. Biochemical and Biophysical Research Communications 2007;355:611. [PubMed: 17316559]